SIBIONICS y PharmaSens exploran nuevos horizontes en la administración automatizada de insulina en la EASD 2026

ConferenceinsulinPositive

AI Analysis

Summary

SiBionics and PharmaSens presented their automated insulin administration vision at the 2026 EASD conference, linking continuous glucose monitoring with diabetes care innovation. The presentation unveiled the "See More, Act Earlier" initiative focused on advancing automated insulin delivery systems.

Importance:2/10

Sentiment:

0.30

diabetesinsulin administrationcontinuous monitoringEASD 2026automated delivery

Read the original article

Published by PR Newswire Biotech on October 8, 2026 2:21 AM

Read Original